Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | -0.34 | -0.35 | -0.01 | -2.94% |
2024-05-09 | 2024-03 | -0.36 | -0.34 | 0.02 | 5.56% |
2024-03-27 | 2023-12 | -0.35 | -0.33 | 0.02 | 5.71% |
2023-11-07 | 2023-09 | -0.4 | -0.39 | 0.01 | 2.50% |
2023-08-10 | 2023-06 | -0.44 | -0.32 | 0.12 | 27.27% |
2023-05-11 | 2023-03 | -0.49 | -0.4 | 0.09 | 18.37% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-13 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-10 | B. Riley Securities | Upgrade | Buy | Buy |
2023-07-11 | JMP Securities | Upgrade | Market Outperform | Market Outperform |
2023-05-14 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-03-30 | JMP Securities | Upgrade | Market Outperform | |
2023-03-21 | JMP Securities | Upgrade | Market Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-08-18 | DRUTZ DAVID J | Director | 0.00 | Sale |
2024-01-30 | EISENSTADT RICHARD I | Chief Financial Officer | 45.01K | Stock Award(Grant) |
2024-02-01 | GARG VIPIN K. | Chief Executive Officer | 292.03K | Conversion of Exercise of derivative security |
2022-08-11 | GILL JOHN M | Director | 2.77K | Sale |
2024-07-30 | HARRIS MATTHEW SCOTT | Officer | 55.12K | Stock Award(Grant) |
2024-07-30 | JORDT RAYMOND M | Officer | 14.66K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 3.66M | 12.93M | 6.95% |
2023-06-29 | Nuveen Asset Management, LLC | 3.46M | 12.21M | 6.57% |
2023-06-29 | Vanguard Group Inc | 3.31M | 11.67M | 6.27% |
2023-06-29 | Tang Capital Management, LLC | 2.75M | 9.71M | 5.22% |
2023-06-29 | Marshall Wace LLP | 2.06M | 7.27M | 3.91% |
2023-06-29 | Laurion Capital Management, LP | 1.84M | 6.49M | 3.49% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | College Retirement Equities Fund-Stock Account | 2.00M | 7.05M | 3.79% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.62M | 5.71M | 3.07% |
2023-06-29 | College Retirement Equities Fund-Global Equities Account | 1.27M | 4.48M | 2.41% |
2023-08-30 | iShares Russell 2000 ETF | 1.18M | 3.00M | 2.25% |
2023-06-29 | Vanguard Extended Market Index Fund | 621.63K | 2.19M | 1.18% |
2023-06-29 | Vanguard Horizon Fund-Strategic Small-Cap Equity Fund | 490.56K | 1.73M | 0.93% |
Dividend | Date |
---|---|
291 | 2017-02-07 |
2.91 | 2017-02-06 |
291.003 | 2017-01-20 |
Split | Date |
---|---|
1 : 30 | 2018-09-14 |
10 : 1 | 2017-05-05 |
-
Pablo, here’s another company $HUMA
-
-
-
-
Altimmune to Present Pemvidutide Clinical Data at Upcoming NASH-TAG Conference January 8, 2022
-
$ALT Management here is Pathetic. Losers!
-
$ALT Institutions are accumulating many shares. They now hold 70% or more of shares. They are not being kept in the dark….
-
$ALT A Slideshow of data will be presented immediately “after” the Conference Call. If the data wasn’t superb, why the hell would they do a slide presentation after the conference?? Exactly, it’s superb!
Going much higher. -
$ALT Great Data News Soon Then to the Moon
-
$ALT Great Data news coming soon
-
$ALT SIXTEEN US states have adult obesity rates of at least 35%
https://mol.im/a/9994855 -
$ALT Traders can play their game but this works in one of the hottest areas there is. Weight Loss.
Lots of weight loss and lots of profit gains…
Relax, it works and enormous gains soon -
$ALT. Shorts will get slaughtered soon. Squeezed to pain. Data will be exceptional. Very soon indeed
-
Altimmune: Emerging Position In Competitive Space, But Risks Remain
seekingalpha.com • -
ALT5 Sigma Appoints Peter Tassiopoulos as Chief Executive Officer
accesswire.com • -
ALT 5 Sigma to Exhibit at SiGMA Budapest September 2-4, 2024
accesswire.com • -
ALT5 Sigma Reports Fiscal Financial Results for Second Quarter 2024
accesswire.com • -
3 Promising Biotech Stocks for the Long-Term: August 2024
investorplace.com • -
The 7 Best Under $10 Stocks to Buy in August 2024
investorplace.com • -
Altimmune, Inc. (ALT) Q2 2024 Earnings Call Transcript
seekingalpha.com • -
3 Undervalued Biotech Stocks With Breakout Potential
investorplace.com • -
Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
investorplace.com • -
7 Bullish Stock Picks With the Potential to Turn $5K Into $50K
investorplace.com •